Editorial lead
Farshad Mobini
Founder and editorial lead · Stockholm
Farshad is an entrepreneur with a master's degree in entrepreneurship and a background in international business. He started LYO after finding that every source on peptides was either selling something or repeating someone who was. He is not a clinician or a scientist, and LYO is built so that it doesn't need him to be: the methodology is public, every grade is referenced, and anyone can check the work.
Scientific review: LYO is recruiting an independent reviewer with a pharmacology or clinical background. Until that seat is filled, every page says so here rather than pretending otherwise.
How a page gets written
Each compound page starts with the primary literature — the trials themselves, not summaries of them — and a search of the registries for anything unpublished. Every claimed effect becomes a row on the evidence matrix with a grade, an effect size and the human studies behind it. The first paragraph is written last, once the matrix exists, because it has to be defensible line by line. The full rules are on the methodology page.
Money
LYO has no revenue. There are no affiliate links, no sponsored placements, no vendor relationships and no advertising. If that ever changes, it will be disclosed here and on every affected page before it takes effect. The data is published under CC BY 4.0 so that the grades can be checked, reused and cited without permission.
Corrections and contact
If a grade is wrong, the fastest way to fix it is to send the study we missed. Corrections are logged on the affected page's change log, dated, and never made silently. Write to hello@lyoresearch.com.